RXO, Inc. (NYSE:RXO) Director Christine S. Breves Purchases 5,100 Shares

RXO, Inc. (NYSE:RXO) Director Christine S. Breves purchased 5,100 shares of RXO stock in a transaction dated Friday, November 17th. The stock was bought at an average price of $19.90 per share, with a total value of $101,490.00. Following the completion of the purchase, the director now directly owns 6,948 shares of the company’s stock, valued at $138,265.20. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

RXO Price Performance

RXO stock traded down $0.12 during mid-day trading on Monday, reaching $19.85. 545,119 shares of the company’s stock traded hands, compared to its average volume of 1,047,641. The company has a market cap of $2.32 billion and a price-to-earnings ratio of -1,997.00. The stock has a 50 day moving average of $18.64 and a two-hundred day moving average of $19.84. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.76. RXO, Inc. has a 12-month low of $15.67 and a 12-month high of $23.74.

RXO (NYSE:RXO) last released its quarterly earnings results on Tuesday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $976.00 million for the quarter, compared to the consensus estimate of $957.88 million. RXO had a negative net margin of 0.05% and a positive return on equity of 10.55%. RXO’s revenue was down 14.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.11 earnings per share. Equities analysts forecast that RXO, Inc. will post 0.28 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Oppenheimer reiterated an “outperform” rating and issued a $24.00 price target on shares of RXO in a research note on Monday, August 7th. Susquehanna cut their target price on shares of RXO from $14.00 to $13.00 and set a “negative” rating for the company in a research report on Tuesday, October 3rd. Stifel Nicolaus cut their target price on shares of RXO from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Monday, October 16th. JPMorgan Chase & Co. lowered shares of RXO from a “neutral” rating to an “underweight” rating and cut their target price for the company from $17.00 to $16.00 in a research report on Wednesday, October 11th. Finally, Morgan Stanley cut their target price on shares of RXO from $20.00 to $18.00 and set an “equal weight” rating for the company in a research report on Monday, October 2nd. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.81.

Institutional Investors Weigh In On RXO

A number of hedge funds have recently bought and sold shares of the business. WASHINGTON TRUST Co bought a new position in RXO during the first quarter valued at $26,000. Bessemer Group Inc. bought a new position in RXO during the fourth quarter valued at $26,000. Tilia Fiduciary Partners Inc. bought a new position in RXO during the first quarter valued at $30,000. Allspring Global Investments Holdings LLC increased its position in RXO by 6,329.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,993 shares of the company’s stock valued at $39,000 after acquiring an additional 1,962 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC bought a new position in RXO during the fourth quarter valued at $39,000. Hedge funds and other institutional investors own 92.73% of the company’s stock.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. The company also offers brokered services for managed transportation, last mile, and freight forwarding. RXO, Inc was founded in 2022 and is based in Charlotte, North Carolina.